ArticleJournal of Alzheimer's disease : JAD2019
Measuring Alzheimer's Disease and Other Dementias in Diverse Populations Using Medicare Claims Data.
Article in Journal of Alzheimer's disease : JAD, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
34 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.
- Case Definition for Diagnosed Alzheimer Disease and Related Dementias in Medicare.JAMA network open · 2024Pooled it
- Perceived Control, Cognitive Training, and Incident Alzheimer's Disease and Related Dementias in the ACTIVE Study.The journals of gerontology. Series B, Psychological sciences and social sciences · 2025Trial
- The cost of dementia in the United States in 2026.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026Article
- Edentulism and risk of all-cause dementia and Alzheimer's disease: A competing risk analysis by cognitive status.Journal of Alzheimer's disease : JAD · 2026Article
- Prevalence and Characteristics of Prehabilitation Utilization Among Older Medicare Beneficiaries Undergoing Elective Inpatient Lower Extremity Joint Replacement.Archives of physical medicine and rehabilitation · 2026Article
- Integrating real-world data with gold-standard longitudinal clinical and genomic data to advance precision medicine for the Alzheimer's Disease Research Center Program and beyond: a proof-of-concept data platform.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026Article
- Divergent effects of oral health and genetic risk: competing risks of dementia and mortality.Innovation in aging · 2026Article
- Role of PCPs in diagnosing dementia in traditional Medicare and Medicare Advantage.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025Observational
- Causal effect of conventional anti-dementia drugs on economic burden: an orthogonal double/debiased machine learning approach.BMC geriatrics · 2025Article
- Real-World Evidence of Brexpiprazole Use and 6-Month Mortality, Hospitalization, and Emergency Department Visits Among Persons With Dementia.Neurology · 2025Article
- Neighborhood disadvantage and the incidence of dementia in US Black women.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025Article
- Prevalence of dementia diagnoses in a safety net health system.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025Article
- The role of a specialized memory clinic supporting primary care providers in a safety net health system.BMC primary care · 2025Article
- Incidence and Prevalence of Alzheimer's Disease in Medicare Beneficiaries.Neurology and therapy · 2025Article
- Association of Dementia Severity at Diagnosis With Health Care Utilization and Costs Around the Time of Incident Diagnosis.Innovation in aging · 2025Article
- Population Dementia Incidence and Direct Oral Anticoagulant Use in a Representative Population With Atrial Fibrillation.Neurology · 2024Article
- The disproportionate burden of Alzheimer's disease and related dementias (ADRD) in diverse older adults diagnosed with cancer.Journal of geriatric oncology · 2023Article
- Identifying Medicare beneficiaries with Alzheimer's disease and related dementia using home health OASIS assessments.Journal of the American Geriatrics Society · 2023Article
- COVID-19 hospitalization and mortality in community-dwelling racially and ethnically diverse persons living with dementia.Journal of the American Geriatrics Society · 2023Article
- Understanding Alzheimer's disease in the context of aging: Findings from applications of stochastic process models to the Health and Retirement Study.Mechanisms of ageing and development · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
We examined how methods used for identifying dementia in administrative claims affected dementia incidence across racial/ethnic populations using a 100% sample of Medicare beneficiaries (n = 23,793,452). We found levels differed by method from 3.1% annual incidence to 3.6% in 2014. Dementia incidence declined from 2007 to 2014, but choice of method differentially impacted levels and trends by race/ethnicity. Methods using codes for dementia diagnosis and drugs to treat symptoms identified proportionally more Hispanics and Asians with dementia than other race/ethnicities, while codes for dementia diagnosis, drugs, and symptoms identified proportionally more whites and American Indians/Alaska Natives with dementia than other race/ethnicities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.